2020 - Member of Academia Europaea
Her primary areas of study are Colorectal cancer, Surgery, Total mesorectal excision, Radiation therapy and Cancer. Her study on Colorectal cancer is covered under Internal medicine. Her Surgery research incorporates themes from Oxaliplatin and Confidence interval.
She has included themes like Clinical trial, Multicenter trial, Retrospective cohort study, Prospective cohort study and Abdominoperineal resection in her Total mesorectal excision study. Her work carried out in the field of Radiation therapy brings together such families of science as Neoadjuvant therapy, Randomized controlled trial, Cumulative incidence and Survival rate. Her Cancer study incorporates themes from Cancer research, Immunology and Pathology.
Iris D. Nagtegaal mostly deals with Colorectal cancer, Internal medicine, Oncology, Cancer and Pathology. Her Colorectal cancer study combines topics from a wide range of disciplines, such as Surgery, Radiation therapy, Radiology and Neoadjuvant therapy. Her research on Surgery often connects related topics like Clinical trial.
In her research on the topic of Internal medicine, Cohort is strongly related with Gastroenterology. Her research investigates the link between Oncology and topics such as Hazard ratio that cross with problems in Proportional hazards model. Cancer and Cancer research are commonly linked in her work.
Her main research concerns Internal medicine, Colorectal cancer, Oncology, Cancer and Gastroenterology. In the field of Internal medicine, her study on Inflammatory bowel disease, Incidence, Cancer registry and Disease overlaps with subjects such as In patient. The Colorectal cancer study combines topics in areas such as Neoadjuvant therapy, Surgery and Tumor budding.
The various areas that Iris D. Nagtegaal examines in her Oncology study include Crc screening, Early onset, Tumour budding and MEDLINE. Her studies deal with areas such as Carcinoma and Family medicine as well as Cancer. In her study, Cohort study is inextricably linked to Cohort, which falls within the broad field of Gastroenterology.
Iris D. Nagtegaal mainly investigates Colorectal cancer, Internal medicine, Oncology, Cancer registry and Pathology. Her studies in Colorectal cancer integrate themes in fields like Neoadjuvant therapy, Pathological, Feces, Radiology and Disease. In her study, which falls under the umbrella issue of Internal medicine, Confidence interval, Cohort and Stage is strongly linked to Gastroenterology.
Her Oncology study integrates concerns from other disciplines, such as Stage III Colon Cancer, Tumour budding, Genetic testing and Genetic predisposition. Her research investigates the connection with Cancer registry and areas like Retrospective cohort study which intersect with concerns in Primary tumor, Surgical oncology, Metastasectomy, Relative survival and Rectum. Her Pathology research includes themes of Gold standard, Molecular phenotype and Cystadenoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Ellen Kapiteijn;Corrie A.M. Marijnen;Iris D. Nagtegaal;Hein Putter.
The New England Journal of Medicine (2001)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
H J Schmoll;E Van Cutsem;A Stein;V Valentini.
Annals of Oncology (2012)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn;Carrie A. M. Marijnen;Iris D. Nagtegaal;Elma Meershoek-Klein Kranenbarg.
Lancet Oncology (2011)
The TME Trial After a Median Follow-Up of 6 Years: Increased Local Control but No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma
Koen C. M. J. Peeters;Corrie A. M. Marijnen;Iris D. Nagtegaal;Elma Klein Kranenbarg.
Annals of Surgery (2007)
What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer
Iris D. Nagtegaal;Phil Quirke.
Journal of Clinical Oncology (2008)
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell.
The Journal of Pathology (2014)
Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.
Iris D. Nagtegaal;Corrie A. M. Marijnen;Elma Klein Kranenbarg;Cornelis J. H. Van De Velde.
The American Journal of Surgical Pathology (2002)
Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control
Iris D. Nagtegaal;Cornelis J.H. van de Velde;Erik van der Worp;Ellen Kapiteijn.
Journal of Clinical Oncology (2002)
Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis
Geert Litjens;Clara I. Sánchez;Nadya Timofeeva;Meyke Hermsen.
Scientific Reports (2016)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea.
The Lancet (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: